Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis-Reference-Cited by-同舟云学术

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

Published:2009-03 Issue:3 Volume:15 Page:220-231
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Pàez-Ribes Marta,Allen Elizabeth,Hudock James,Takeda Takaaki,Okuyama Hiroaki,Viñals Francesc,Inoue Masahiro,Bergers Gabriele,Hanahan Douglas,Casanovas Oriol

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference45 articles.

1. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients;Batchelor;Cancer Cell,2007

2. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma;Bendell;Cancer,2003

3. The Gliomas;Berger,1999

4. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008

5. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors;Bergers;J. Clin. Invest.,2003

Cited by 2055 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy;Coordination Chemistry Reviews;2024-10

3. Prediction of the response to antiangiogenic sunitinib therapy by non-invasive hybrid diffuse optics in renal cell carcinoma;Biomedical Optics Express;2024-09-06

4. Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance;Current Issues in Molecular Biology;2024-09-05

5. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09